TY - JOUR
T1 - Hepatic glycogenolysis is determined by maternal high-calorie diet via methylation of Pygl and it is modified by oteocalcin administration in mice
AU - Kawakubo-Yasukochi, Tomoyo
AU - Yano, Ena
AU - Kimura, Soi
AU - Nishinakagawa, Takuya
AU - Mizokami, Akiko
AU - Hayashi, Yoshikazu
AU - Hatakeyama, Yuji
AU - Ohe, Kenji
AU - Yasukochi, Atsushi
AU - Nakamura, Seiji
AU - Jimi, Eijiro
AU - Hirata, Masato
N1 - Funding Information:
The authors thank Professor Manabu Nakashima, who has retired from the Department of Immunological and Molecular Pharmacology, Faculty of Pharmaceutical Sciences, Fukuoka University, Japan, for helpful discussions; Dr. Atsushi Doi, Dr. Hiroko Hagiwara, and Dr. Kaori Yasuda (Cell Innovator Co., Ltd., Fukuoka, Japan) for assistance with the sequencing analysis and useful discussion; and Hikari Takeshima and Mayu Seida, undergraduate students in the Department of Biomedical Science, Kyushu University School of Medicine, for technical assistance. We also appreciate the technical assistance provided by the Research Support Center, Research Center for Human Disease Modeling, Kyushu University Graduate School of Medical Sciences. This work was supported by the Japan Society for the Promotion of Science (KAKENHI grants JP17H01595 and JP20H03854 to M.H., JP19K10052 to T.K.-Y., JP18K09521 to A.M., and JP19K10269 to A.Y.), the Shin-nihon Foundation of Advanced Medical Treatment Research , the Danone Institute of Japan Foundation, Japan , and the Mishima Kaiun Memorial Foundation . We also thank Mark Cleasby, Ph.D. from Edanz ( https://jp.edanz.com/ac ) for editing a draft of this manuscript.
Funding Information:
The authors thank Professor Manabu Nakashima, who has retired from the Department of Immunological and Molecular Pharmacology, Faculty of Pharmaceutical Sciences, Fukuoka University, Japan, for helpful discussions; Dr. Atsushi Doi, Dr. Hiroko Hagiwara, and Dr. Kaori Yasuda (Cell Innovator Co. Ltd. Fukuoka, Japan) for assistance with the sequencing analysis and useful discussion; and Hikari Takeshima and Mayu Seida, undergraduate students in the Department of Biomedical Science, Kyushu University School of Medicine, for technical assistance. We also appreciate the technical assistance provided by the Research Support Center, Research Center for Human Disease Modeling, Kyushu University Graduate School of Medical Sciences. This work was supported by the Japan Society for the Promotion of Science (KAKENHI grants JP17H01595 and JP20H03854 to M.H. JP19K10052 to T.K.-Y. JP18K09521 to A.M. and JP19K10269 to A.Y.), the Shin-nihon Foundation of Advanced Medical Treatment Research, the Danone Institute of Japan Foundation, Japan, and the Mishima Kaiun Memorial Foundation. We also thank Mark Cleasby, Ph.D. from Edanz (https://jp.edanz.com/ac) for editing a draft of this manuscript.
Publisher Copyright:
© 2021 The Authors
PY - 2021/12
Y1 - 2021/12
N2 - Objective: Accumulating evidence indicates that an adverse perinatal environment contributes to a higher risk of metabolic disorders in the later life of the offspring. However, the underlying molecular mechanisms remain largely unknown. Thus, we investigated the contribution of maternal high-calorie diet and osteocalcin to metabolic homeostasis in the offspring. Methods: Eight-week-old C57Bl/6N female mice were mated with age-matched males and allocated randomly to three groups: a normal-diet (ND) or a high-fat, high-sucrose diet group, which was administered either saline (control) or GluOC (10 ng/g body mass) from the day of mating to that of delivery, and the dams were fed a ND after the delivery. Pups weaned at 24 days after birth were analyzed. Results: A maternal high-fat, high-sucrose diet during pregnancy causes metabolic disorders in the liver of the offspring via hypermethylation of the Pygl gene, encoding glycogen phosphorylase L, which mediates hepatic glycogenolysis. The reduced expression of Pygl induced by the maternal diet causes the hepatic accumulation of glycogen and triglyceride in the offspring, which remains in adulthood. In addition, the administration of uncarboxylated osteocalcin during pregnancy upregulates Pygl expression via both direct CREBH and ATF4 and indirect epigenomic pathways, mitigating the maternal diet-induced obesity and abnormal glucose and lipid metabolism in adulthood. Conclusions: We propose that maternal energy status is reflected in the hepatic glycogenolysis capacity of the offspring via epigenetic modification of Pygl and uncarboxylated osteocalcin regulates glycogenolysis.
AB - Objective: Accumulating evidence indicates that an adverse perinatal environment contributes to a higher risk of metabolic disorders in the later life of the offspring. However, the underlying molecular mechanisms remain largely unknown. Thus, we investigated the contribution of maternal high-calorie diet and osteocalcin to metabolic homeostasis in the offspring. Methods: Eight-week-old C57Bl/6N female mice were mated with age-matched males and allocated randomly to three groups: a normal-diet (ND) or a high-fat, high-sucrose diet group, which was administered either saline (control) or GluOC (10 ng/g body mass) from the day of mating to that of delivery, and the dams were fed a ND after the delivery. Pups weaned at 24 days after birth were analyzed. Results: A maternal high-fat, high-sucrose diet during pregnancy causes metabolic disorders in the liver of the offspring via hypermethylation of the Pygl gene, encoding glycogen phosphorylase L, which mediates hepatic glycogenolysis. The reduced expression of Pygl induced by the maternal diet causes the hepatic accumulation of glycogen and triglyceride in the offspring, which remains in adulthood. In addition, the administration of uncarboxylated osteocalcin during pregnancy upregulates Pygl expression via both direct CREBH and ATF4 and indirect epigenomic pathways, mitigating the maternal diet-induced obesity and abnormal glucose and lipid metabolism in adulthood. Conclusions: We propose that maternal energy status is reflected in the hepatic glycogenolysis capacity of the offspring via epigenetic modification of Pygl and uncarboxylated osteocalcin regulates glycogenolysis.
UR - http://www.scopus.com/inward/record.url?scp=85119289885&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85119289885&partnerID=8YFLogxK
U2 - 10.1016/j.molmet.2021.101360
DO - 10.1016/j.molmet.2021.101360
M3 - Article
C2 - 34673295
AN - SCOPUS:85119289885
SN - 2212-8778
VL - 54
JO - Molecular Metabolism
JF - Molecular Metabolism
M1 - 101360
ER -